why do glp-1 drugs stop working Working, and What to Do About It?: Medscape TrimRX | Why Do GLP-1

New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.

It's more effective than semaglutide (a single GLP-1 agonist) for weight loss and blood sugar control

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) have proven efficacy and safety in randomized clinical trials and observational real-life studies

- ( )

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity

Evidence-based guidance on safety, monitoring, and when to discuss treatment with your healthcare team.